Financial reports
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K
2023 FY
Annual report
18 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
20 Mar 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
Current reports
8-K
Exagen Inc. Announces Changes to the Board of Directors
26 Apr 24
8-K
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
18 Mar 24
8-K
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
8 Jan 24
8-K
Departure of Directors or Certain Officers
11 Dec 23
8-K
Entry into a Material Definitive Agreement
17 Nov 23
8-K
Exagen Inc. Reports Strong Third Quarter 2023 Results
13 Nov 23
8-K
Entry into a Material Definitive Agreement
26 Oct 23
8-K
Exagen Inc. Reports Strong Second Quarter 2023 Results
7 Aug 23
8-K
Exagen Inc. Appoints Paul Kim to Board of Directors
24 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
29 Nov 23
S-3/A
Shelf registration (amended)
27 Nov 23
424B5
Prospectus supplement for primary offering
20 Nov 23
S-3
Shelf registration
17 Nov 23
S-8
Registration of securities for employees
18 May 23
424B5
Prospectus supplement for primary offering
15 Sep 22
S-8
Registration of securities for employees
11 May 22
S-8
Registration of securities for employees
11 May 21
424B5
Prospectus supplement for primary offering
23 Mar 21
424B5
Prospectus supplement for primary offering
22 Mar 21
Proxies
DEF 14A
Definitive proxy
26 Apr 24
DEFA14A
Additional proxy soliciting materials
24 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
27 Apr 21
DEF 14A
Definitive proxy
27 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
Other
EFFECT
Notice of effectiveness
30 Nov 23
CORRESP
Correspondence with SEC
28 Nov 23
UPLOAD
Letter from SEC
22 Nov 23
EFFECT
Notice of effectiveness
20 Nov 20
CORRESP
Correspondence with SEC
17 Nov 20
UPLOAD
Letter from SEC
16 Nov 20
EFFECT
Notice of effectiveness
19 Sep 19
CERT
Certification of approval for exchange listing
17 Sep 19
CORRESP
Correspondence with SEC
16 Sep 19
CORRESP
Correspondence with SEC
16 Sep 19
Ownership
4
Kamal Adawi
6 Mar 24
4
JOHN ABALLI
4 Mar 24
4
Kamal Adawi
22 Feb 24
4
JOHN ABALLI
22 Feb 24
SC 13G/A
LYTTON LAURENCE W
14 Feb 24
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 24
SC 13G/A
Stonepine Capital Management, LLC
13 Feb 24
SC 13G/A
TULLIS DICKERSON CAPITAL FOCUS III, L.P.
13 Feb 24
SC 13G/A
WASATCH ADVISORS LP
9 Feb 24
4
Kamal Adawi
8 Feb 24